FDA Drug Application (022023) for EMEND by MERCK AND CO INC

Back to FDA Applications sponsored by MERCK AND CO INC

Application Number022023
Product Number001
FormPOWDER;INTRAVENOUS
DosageEQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEMEND
Active IngredientFOSAPREPITANT DIMEGLUMINE

Active IngredientCount
List of drugs with Active Ingredient APREPITANT2
List of drugs with Active Ingredient FOSAPREPITANT DIMEGLUMINE2


Back to FDA Applications sponsored by MERCK AND CO INC